The Problem and Paradox of Bad Trips – Part 1
Bad trips look much different in psychedelic therapy than in uncontrolled settings.
Health - Page 8
The Nuances of Ketamine’s Neurochemistry
What's similar and different about the R and S isomers of ketamine?
‘Pharmacopeia’ Season Finale Features Cutting Edge Psychedelic Research
“We have some [compounds] now that are unlike anything you’ve ever seen before.”
The Role of Oxytocin in MDMA’s Prosocial Effects
The link between oxytocin and MDMA is less straightforward than once thought.
Psychedelics Show Promise for Treating Dementia
“…this stands up to scientific rigor and is worthy of further exploration.”
Insight into Ayahuasca’s Antidepressant Effects
Research indicates that C-Reactive Protein may play a vital role in combating Treatment-Resistant Depression.
Researchers Synthesize Novel Compound, Tabernanthalog, a Non-Hallucinogenic Ibogaine Analog
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
What is the Mystical Experience Questionnaire?
The MEQ is a self-report measure that provides insight into a key aspect of the psychedelic experience.
The Effects of Psilocybin on Morality and Empathy
This study is the first of its kind to suggest that psilocybin enhances emotional empathy but does not affect moral behavior.
Are the Subjective Effects of Psychedelics Necessary for Their Therapeutic Benefits?
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.